Biodefense, Hospital Hygiene, Food Safety and environment are also considered in this service offers.
Methodologies such as qPCR, Western Blot, infectivity assays (cell-based or animal models depend on pathogen agents) are used for this field.
Compatibility between the surfaces of the instruments and the Biodecontamination process is considered .
This notion was particularly considered for Prions (Transmissible Spongiform Encephalopathy (TSE) agents) , about which Bertin Pharma was heavily involved, both at the level of industrials and of regulatory agencies. For these pathogens, experiments we do comply with the Prion Standard Protocol (PSP)with firstly in vitro steps (first assay against the 263K and an additional assay using other prion strains closer of human risk) and then the in vivo step (263K strain). Prion experiments comply with PSP.
This activity is carried out in partnership with 3 European specialised companies in: